Advertisements

Bayotensin

Quick links to important sections

Bayotensin

Advertisements
Advertisements

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Bayotensin

What is Bayotensin? (Composition: Nitrendipine)

Property Description
Active ingredient Nitrendipine (INN)
Form Oral (Tablet or Softgel Capsule)
Pharmacological Class Calcium Channel Blocker (CCB)
General Purpose Mitigation of high blood pressure
Origin Synthetic (Dihydropyridine Derivative)

What Type of Medicine is Bayotensin?

Bayotensin is a prescription pharmaceutical preparation whose activity is derived entirely from its single active component, Nitrendipine. This medication belongs to the prominent pharmacological class known as Calcium Channel Blockers (CCBs), specifically identified as a dihydropyridine derivative. The active substance, Nitrendipine, is a synthetic small molecule drug, not a compound derived from natural sources.

The drug is classified as an antihypertensive agent. Nitrendipine is used to treat high blood pressure, which defines its core medical purpose. This confirms that the medication is primarily utilized to help manage and lower persistently elevated blood pressure. As a dihydropyridine, Bayotensin is clinically recognized for its selective focus on the peripheral blood vessels, a differentiating factor in the selection of anti-hypertensive therapy. The medication is generally intended to provide an anti-hypertensive action, supporting overall cardiovascular health.


How is Bayotensin Structured and What is its Purpose?

Bayotensin is conventionally prepared as a single-ingredient product designed for oral administration, most commonly manufactured in the form of a tablet or softgel capsule. The preparation contains the active substance Nitrendipine combined with various solid pharmaceutical excipients required for its final form.

The core purpose of this preparation is rooted in its established mechanism as an L-type calcium channel inhibitor. By inhibiting the entry of calcium ions into the artery walls, the preparation prompts the muscles in the blood vessels to relax, a process known as vasodilation. This physical widening of the arteries results in a reduction of peripheral vascular resistance, which lowers the pressure exerted on the vessel walls. Nitrendipine functions by causing this peripheral vasodilation. This confirms that the drug helps ease blood flow by effectively widening the blood vessels.

Advertisements

What side effects are possible with Bayotensin?

Possible Side Effects and Safety Information

The safety profile of Bayotensin (Nitrendipine) is structured according to classifications used by major regulatory bodies, detailing adverse reactions by frequency and the body systems affected. These classifications distinguish between commonly reported effects and rare, clinically significant reactions.

Adverse Reaction Classification

The adverse reactions are categorized based on regulatory standards. Effects designated as Common include headache, dizziness, peripheral oedema (swelling), vasodilation (flushing), and palpitations. Certain effects, such as Headache and Flushing, are officially noted to be more common during the initial phases of treatment.

Reactions categorized as Uncommon include hypotension (low blood pressure), certain gastrointestinal disorders like nausea or abdominal pain, and new onset or worsening Angina pectoris.

Organ System Involvement

Adverse effects are grouped into System-Organ Classes (SOCs). Key affected systems include Vascular disorders (e.g., oedema, hypotension), Nervous system disorders (e.g., headache), and Cardiac disorders (e.g., palpitations, tachycardia). Rare effects, such as Hepatitis or Cholestasis, are classified under Hepatobiliary disorders.

Serious Safety Considerations and Limitations

Regulatory documents list certain reactions as serious or clinically important, including Severe Hypotension and severe Hypersensitivity reactions. Use is formally restricted or contraindicated in specific contexts, such as in patients experiencing Cardiogenic shock or those with Severe Hepatic Impairment. Additionally, caution must be exercised when the medication is used alongside strong inhibitors of the CYP3A4 enzyme, as this may lead to increased exposure and heightened risk of adverse effects.

Advertisements

Overdose and Emergency Response

Overdose of Bayotensin (Nitrendipine) is officially documented in regulatory sources and is primarily characterized by the severe consequences of its exaggerated pharmacological activity. Documented clinical manifestations typically involve profound cardiovascular system effects, specifically severe hypotension (extremely low blood pressure) and irregularities in heart rhythm, which may include Reflex Sinus Tachycardia or, in cases of severe toxicity, Bradycardia. Central nervous system symptoms, such as drowsiness, confusion, agitation, and slurred speech, along with hyperglycemia, are also officially noted.

An overdose is classified as potentially life-threatening due to the risk of progression to shock, cardiac arrest, or coma. Regulatory guidance mandates that individuals seek medical help right away upon known or suspected ingestion. Immediate contact with emergency services is required. Because delayed toxicity is possible, particularly with sustained-release formulations, hospital monitoring and prolonged observation are often required, even in asymptomatic patients.

Management is documented as symptomatic and supportive, addressing the specific manifestations through measures such as intravenous fluids, vasopressors, or specific therapeutic agents, as no single specific antidote is known.

Advertisements

Therapeutic Uses of Bayotensin

What Bayotensin Treats: Main Uses and Benefits

Bayotensin (Nitrendipine) is commonly used for managing conditions related to the cardiovascular system, and supports long-term management of systemic imbalance and symptomatic relief. The drug is used to help manage high blood pressure and certain forms of heart-related chest pain.

Its primary therapeutic use is the long-term management of Essential Hypertension, a condition characterized by persistently elevated blood pressure readings. The medication is also relevant for easing the symptoms associated with recurrent Angina Pectoris, including Chronic Stable and Prinzmetal's Variant Angina. This use supports the management of conditions marked by increased physiological stress and helps ease symptoms that may create noticeable physiological strain.

“Bayotensin provides supportive relief in contexts marked by increased discomfort and assists with maintaining functional stability in the face of chronic cardiovascular stress.”

The drug is applied across various clinical contexts, allowing its use as a single agent or as part of combination therapy when symptoms are difficult to manage. Its application is considered relevant for specific patient groups, such as older adults or those managing hypertension alongside other conditions like Type 2 Diabetes.


Quick Fact: Symptom Domains

Quick Fact: Primary Symptomatic Focus

The core therapeutic benefit contributes to easing the overall burden of systemic stress and supports patients during episodes of heightened discomfort related to recurrent chest pain.

Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Bayotensin?

This section defines the officially documented eligibility rules for using Bayotensin (Nitrendipine) as prescribed by regulatory authorities. Eligibility is determined by specific patient populations and pre-existing clinical conditions.

Bayotensin is contraindicated and must not be used by patients with a known hypersensitivity to the active substance or other dihydropyridines. Absolute prohibitions also apply to patients experiencing cardiovascular shock, severe aortic stenosis, unstable angina, or the acute phase within one month following a myocardial infarction. Use is also contraindicated during pregnancy and with the concomitant administration of Rifampicin.

Age and Condition Restrictions

Category Regulatory Status
Pediatric Use (Under 18) Not Recommended; safety and efficacy are not established.
Geriatric Use (Older Adults) Use is established, but often requires careful dose titration.
Hepatic Function Contraindicated in severe impairment; Caution advised in mild-to-moderate impairment.
Lactation Not Recommended; the substance is excreted into breast milk.

Adults with confirmed Essential Hypertension or specific types of Angina Pectoris are the populations for whom use is officially established.

Advertisements

What should I know about interactions with other medicines?

Bayotensin (Nitrendipine) is a calcium channel blocker that can interact with various medications, leading to changes in its effectiveness or increasing the risk of side effects. It is essential to inform your healthcare provider about all prescription drugs, over-the-counter medicines, and herbal supplements you are taking.

Potential Drug Interactions

Type of Interacting Medicine Potential Effect of Interaction
Other Blood Pressure Medicines (e.g., Beta-blockers, ACE inhibitors, Diuretics) Can significantly increase the blood-pressure-lowering effect (hypotension). Close monitoring and dose adjustments may be required.
Digoxin (for heart failure/irregular heartbeat) Bayotensin can increase the blood levels of Digoxin, raising the risk of Digoxin toxicity. Digoxin levels should be monitored.
Antifungals (e.g., Ketoconazole, Itraconazole) and Certain Antibiotics (e.g., Erythromycin, Clarithromycin) These strong CYP3A4 inhibitors can increase the concentration of Bayotensin in the blood, enhancing its effects and potential side effects.
Phenytoin, Phenobarbital, Carbamazepine, Rifampicin These CYP3A4 inducers can decrease the concentration of Bayotensin in the blood, potentially reducing its therapeutic effect.
Cimetidine (antacid) May slightly increase Bayotensin levels in the blood.

Interaction with Food and Supplements

Consumption of grapefruit or grapefruit juice should be avoided while taking Bayotensin. Grapefruit can significantly increase the blood levels of Bayotensin, which may lead to an increased risk of side effects, such as very low blood pressure.

Advertisements

Mechanism of Action

How Bayotensin Works

Bayotensin (Nitrendipine) is a dihydropyridine class calcium channel blocker. Its action is primarily directed at voltage-dependent L-type calcium channels embedded within the membranes of vascular smooth muscle cells. The drug acts as an inhibitor at this site, decreasing the permeability of the channel to extracellular calcium ions.

This reduced influx of calcium suppresses the necessary molecular steps for smooth muscle contraction. The resulting intracellular consequence is vascular smooth muscle relaxation, a process known as vasodilation, particularly in the systemic arteries. This mechanistic cascade leads to a physiological consequence of decreased total peripheral resistance and modulation of arterial tone.

Secondary mechanistic effects may include the potential for inducing the release of nitric oxide ( NO) from the vascular endothelium, which further facilitates vasodilation. Additionally, Bayotensin promotes natriuresis (sodium excretion) and alters fluid processes by influencing mediator activity in the renal system. The combined effects represent the drug's full pharmacodynamic profile.

Advertisements

Dosage and Administration Information

Bayotensin (Nitrendipine) is administered exclusively via the oral route for long-term management of chronic conditions. The medicine is prepared as a tablet or capsule, which must be swallowed whole with water and should not be crushed or chewed.

Treatment is typically initiated at a dose of 20 milligrams (mg) taken once daily. The dosage may be adjusted upward, but it should not exceed the maximum daily dose of 40 mg. This maximum is sometimes administered as two divided doses of 20 mg.

The preparation may be consumed with or without food. However, a specific administration constraint is the requirement to avoid the consumption of grapefruit juice throughout the treatment period, as this fruit may interfere with the drug's metabolism.

Dosing requires modification for specific patient populations. For older adults, treatment often begins at a lower dose, such as 10 mg per day. Similarly, individuals with hepatic impairment require a significantly reduced initial dose, typically starting at 5 mg or 10 mg once daily. These guidelines define the procedural approach to using Bayotensin, ensuring consistent administration patterns.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Bayotensin

Bayotensin (Nitrendipine) was studied in research settings that explored blood pressure patterns and specific heart-related conditions. The available research is primarily derived from Randomized Controlled Trials (RCTs) and meta-analyses that observed how the treatment influences certain outcomes and physiological states.


Evidence for Use in Managing Essential Hypertension

Research has explored the use of Bayotensin in patients with high blood pressure through large-scale Randomized Controlled Trials (RCTs) and comprehensive systematic reviews. These studies included general adult populations, with particular research exploring specific groups, such as those with mild hypertension and older adults (age > 60). These trials monitored changes in blood pressure readings, both systolic and diastolic, over defined time intervals.

In these research settings, studies reported measurements of blood pressure patterns observed across various study populations. Studies also monitored the achievement of pre-defined blood pressure targets. Furthermore, long-term outcome trials (some spanning multiple years) tracked the observed frequency of major cardiovascular events, such as stroke or coronary events, and mortality rates in the observed groups.

While the evidence contributes to the broader evidence landscape for treating high blood pressure, further research may be needed to explore whether specific non-blood pressure related differences in outcomes exist compared to every other major drug class used for hypertension management.


Evidence for Symptom Management in Angina Pectoris

Bayotensin was evaluated in patients with conditions characterized by fluctuating or episodic manifestations, such as chronic stable angina and Prinzmetal's Variant Angina. The trials, which included RCTs, were applied in research contexts involving fluctuating or unstable symptoms where outcomes related to physical discomfort were measured.

The research examined changes in the frequency of chest pain symptoms and measured patterns in exercise capacity and duration. Trials also monitored the patient-reported need for rescue medications used during episodes where symptoms become more noticeable. Findings describe patterns observed in the measured frequency of symptoms and in measures of physical performance during controlled exercise testing.


Studies Examining Secondary Prevention of Cardiovascular Events

Large-scale, prospective comparative clinical trials have studied Bayotensin's role in a specific high-risk population: hypertensive adults who have previously experienced a stroke or transient ischemic attack (TIA). The study evaluated a composite endpoint that tracked the total incidence of all-cause mortality and subsequent cardiovascular or cerebrovascular events.

In these studies, the research monitored a composite endpoint that combined total mortality and subsequent cardiovascular or cerebrovascular events over an intermediate follow-up duration (for example, approximately 2.5 years). Data described patterns related to the observed rates of recurrent events when the compound was compared against a specific alternative anti-hypertensive treatment within the trial.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Bayotensin (FAQ)

Q: Is Bayotensin a beta-blocker or a different type of medicine?

Official drug classification documents state that Bayotensin (Nitrendipine) belongs to the pharmacological class known as Calcium Channel Blockers (CCBs). It is specifically identified as a dihydropyridine derivative and is not classified as a beta-blocker. The medication works by selectively acting on calcium channels in the peripheral blood vessels.

Q: What happens if a dose of Bayotensin is missed?

Patient information from regulatory sources generally addresses what to do if a dose is missed. It advises taking the dose as soon as it is remembered, unless it is nearly time for the next scheduled dose. Importantly, regulatory documents advise skipping the forgotten dose and not taking two doses at once to make up for it.

Q: What type of headaches are associated with starting Bayotensin?

Regulatory documents classify headache as a common side effect of Bayotensin. Official product information notes that these headaches are often observed during the initial phases of treatment as the body adjusts to the medication.

Q: What should be checked by a doctor while taking Bayotensin long-term?

Official prescribing guidelines describe the need for consistent blood pressure monitoring during long-term use. In addition to tracking blood pressure patterns, regulatory documents also highlight the importance of monitoring for certain serious adverse effects, such as signs of liver problems, including jaundice (yellowing of the skin or eyes).

Q: How should changes in diet, like starting a low-sodium plan, be handled while on Bayotensin?

The most explicit dietary caution in the official labeling is the requirement to avoid consuming grapefruit or grapefruit juice throughout treatment. Official patient information indicates that any major changes to a diet, such as starting a low-sodium plan, are recommended to be reviewed with a healthcare provider.

Q: What are the official warnings regarding combining Bayotensin with certain potassium supplements?

Official information indicates that Bayotensin's effect on the renal system may influence the body's electrolyte balance, which includes potassium. Because of this, official information suggests that the use of potassium supplements is recommended to be reviewed by a healthcare provider prior to starting the medicine.

Q: What is the difference between Bayotensin and similar medicines used for blood pressure?

Bayotensin is a type of calcium channel blocker (CCB) that is noted in official documents for its selective action on the peripheral blood vessels. Some prescribing documents also mention that it promotes natriuresis, which is the excretion of sodium, as a part of its blood pressure-lowering effect.

Q: Why is Bayotensin sometimes used along with other blood pressure medicines?

Regulatory information indicates that Bayotensin may be used as part of a combination therapy, often alongside other anti-hypertensive agents, such as ACE inhibitors. The purpose of this combination is generally to enhance the overall blood pressure-lowering effect in patients with elevated blood pressure.

Q: Does Bayotensin treat other conditions besides high blood pressure?

Official documents specify that the medication is indicated for the treatment of Essential Hypertension (high blood pressure). Additionally, regulatory information lists its use for specific heart conditions characterized by chest pain, such as chronic stable angina pectoris and Prinzmetal's variant angina.

Q: Does Bayotensin work by affecting the kidneys?

Regulatory documents indicate that the drug has an effect on the renal system. It is noted to promote natriuresis, which is the process of increased sodium excretion in the urine, influencing the body's fluid processes and contributing to lower blood pressure.

Q: How common is swelling of the hands or feet when taking Bayotensin?

Swelling of the hands or feet, officially termed peripheral oedema, is classified as a Common adverse reaction in regulatory safety documents. This means the effect is frequently reported based on clinical documentation.

Q: Can Bayotensin affect blood sugar levels, especially for people with diabetes?

Official clinical literature generally suggests that Bayotensin does not affect blood sugar control to a clinically relevant degree during long-term use. However, official clinical literature indicates that patients with diabetes may be considered for standard clinical monitoring.

Q: Does Bayotensin affect potassium levels in the blood?

Due to its effects on sodium and fluid balance (natriuresis), the medicine is known to influence electrolyte levels, including potassium. Official documentation indicates that monitoring of blood potassium levels may be necessary.

Q: Are there any side effects that require stopping Bayotensin immediately?

Regulatory patient warnings highlight several serious symptoms for which seeking immediate medical attention is advised. These include signs of very low blood pressure (severe hypotension), shock-like symptoms (like loss of consciousness), or symptoms of severe liver problems (such as yellowing of the skin or eyes).

Q: Do Bayotensin side effects usually go away after a few weeks?

Regulatory documents specifically note that common side effects, such as headache and flushing of the skin, are often experienced during the initial phases of treatment. This observation suggests that these effects may diminish or become less frequent as the body adjusts to the medicine.

Q: How quickly can Bayotensin start to lower blood pressure after taking the first dose?

Official pharmacokinetic information notes that the blood pressure-lowering action of Bayotensin generally begins within one to two hours after the first dose is taken orally.

Q: How long does it typically take to see the full intended effect of Bayotensin?

While the initial blood pressure-lowering effect is seen relatively quickly, the full intended therapeutic effect is assessed over a period of chronic treatment. Regulatory studies follow patients for several weeks or months to determine the full sustained benefit of the medication.

Q: Is it necessary to take Bayotensin every day even if blood pressure seems controlled?

Bayotensin is officially prescribed for the long-term management of chronic conditions, such as high blood pressure. Consistent, daily administration is required to maintain the intended therapeutic effect and sustained blood pressure control.

Q: Does stopping Bayotensin suddenly have a known effect?

Regulatory patient information states that abruptly stopping the medication is not recommended. Stopping suddenly could lead to a rapid increase in blood pressure, a potential rebound effect.

Q: Can Bayotensin be taken with common cold and flu medications?

Regulatory documents state that Bayotensin can interact with other medicines, including those that affect blood pressure. Because some common cold and flu medicines contain ingredients that can raise blood pressure (like decongestants), official information states that any combination is recommended to be reviewed by a healthcare provider.

Q: Does taking Bayotensin require avoiding salt substitutes?

Due to Bayotensin's effects on the body's electrolyte balance, caution is advised regarding products that can affect mineral levels. Since many salt substitutes contain potassium, official caution suggests their use is recommended to be confirmed with a healthcare provider.

Q: Does having diabetes affect who can or cannot use Bayotensin?

Diabetes itself is not listed as an absolute prohibition for the use of Bayotensin in official documents. However, official documents indicate that patients with this condition may be considered for special clinical monitoring.

Q: Does Bayotensin affect your heart rate?

Official documents list both palpitations and tachycardia (an increased heart rate) as associated cardiac side effects. These effects are generally noted as being more common during the initial phase of treatment.

Q: What type of research has been done on the long-term use of Bayotensin?

Long-term research themes have focused on cardiovascular outcomes, including the observed frequency of major events like stroke and coronary events. Research has also tracked the potential for the medication to influence the regression of structural changes in the heart and blood vessels.

Q: Is there information on Bayotensin's use in combination with common cholesterol-lowering medicines?

Official drug interaction information notes that Bayotensin is metabolized by specific liver enzymes. Official drug interaction information suggests that all concurrent medications are recommended to be reviewed by a doctor to assess the potential for interaction.

Q: Does high heat or physical activity require any special precautions when taking Bayotensin?

As Bayotensin works to lower blood pressure, official warnings advise that certain activities may require caution. Strenuous physical activity or exposure to high heat can increase the risk of symptoms like dizziness or lightheadedness due to the drug's effect on blood pressure.

Advertisements

How should Bayotensin be stored and disposed of?

How to Store and Dispose of Bayotensin

Bayotensin (Nitrendipine) must be stored strictly according to official regulatory requirements to maintain its stability.


Storage Conditions

The medicine must be stored at controlled room temperature, typically 20 C to 25 C (68 F to 77 F), with permitted excursions up to 30 C. It is essential to protect Bayotensin from light and moisture and to keep it in the original container, tightly closed. As a critical safety measure, the product must always be stored out of the sight and reach of children.


Disposal Requirements

Unused or expired Bayotensin must be disposed of according to local regulations. The preferred method is using an authorized drug take-back program. If one is unavailable, the medicine should be mixed with an undesirable substance, placed in a sealed container, and discarded in the household trash. It must not be flushed down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Bayotensin found in:

A-Z Index: